Document is current
Any future updates will be listed below
-
Authors
Yeroushalmi, Samuel
Ildardashty, Alexander
Elhage, Kareem G.
Chung, Mimi
Bartholomew, Erin
Hakimi, Marwa
Tahir, Peggy
Naik, Haley B.
Bhutani, Tina
Liao, Wilson
- License Information
-
More Information
Article History
Received: 26 October 2022
Accepted: 3 November 2022
First Online: 18 November 2022
Declarations
:
: Haley Naik has received grant support from Abbvie; consulting fees from 23andme, Abbvie, Aristea Therapeutics, Nimbus Therapeutics, Medscape, and DAVA Oncology; advisory board fees from Boehringer Ingelheim; and investigator fees from Pfizer. She is also an Associate Editor for JAMA Dermatology and an unpaid board member of the US Hidradenitis Suppurativa Foundation. Tina Bhutani is a principal investigator for trials sponsored by Abbvie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has received research grant funding from Novartis and Regeneron. She has been an advisor for Abbvie, Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. Wilson Liao has received research grant funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. The remaining authors have nothing to disclose.
